Hadean Ventures
Venture Capital
Active
Oslo, Norway
23
33M
18
2.56
2
0.22
3
- Areas of investment
Summary
Hadean Ventures appeared to be the VC, which was created in 2014. The main department of described VC is located in the Oslo. The venture was found in Europe in Norway.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Hadean Ventures, startups are often financed by aws Gru00fcnderfonds (aws Founders Fund), Wellington Partners, Ventech. The meaningful sponsors for the fund in investment in the same round are aws Gru00fcnderfonds (aws Founders Fund), Wellington Partners, Versant Ventures.
The important activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. For fund there is no match between the location of its establishment and the land of its numerous investments - Sweden. Among the most successful fund investment fields, there are Medical, B2B. Among the various public portfolio startups of the fund, we may underline Themis Bioscience, AttgeNO, SAGA Diagnostics
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- EUR 144000000
- Fund raised date
- 2023-12-22
Analytics
- Total investments
- 23
- Lead investments
- 2
- Exits
- 3
- Rounds per year
- 2.56
- Follow on index
- 0.22
- Investments by industry
- Biotechnology (16)
- Health Care (9)
- Pharmaceutical (7)
- Medical (5)
- Clinical Trials (3) Show 12 more
- Investments by region
-
- Germany (2)
- United States (3)
- United Kingdom (1)
- Austria (2)
- Denmark (1) Show 6 more
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 0.87
- Avg. company exit year
- 11
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| ARTHEx Biotech | 03 May 2023 | Biotechnology | Early Stage Venture | 49M | Valencian Community, Valencia, Spain |
| Congenica | 30 Apr 2019 | Biotechnology, Health Care, Genetics, Medical, Bioinformatics | Early Stage Venture | 18M | England, Cambridge, United Kingdom |
| HATCHER+ | 04 May 2020 | Venture Capital, FinTech, Artificial Intelligence, Machine Learning, Big Data, Incubators | Early Stage Venture | 5M | Central, Singapore, Singapore |
| Pipeline Therapeutics | 18 Dec 2019 | Pharmaceutical | Early Stage Venture | 32M | United States, California, San Diego |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.